EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Large, Real‐World Cohort Analysis of Arrhythmia Detection and Therapeutic Interventions in Patients With Insertable Cardiac Monitors and Long‐Term Monitoring

Sandeep A Saha iD, Sarah Rosemas iD, Shantanu Sarkar iD, Veronica Ramos, Andrew P Radtke, Shubha Majumder, Mirko De Melis iD, Jiani Zhou, J Jason Sims

Journal of Cardiovascular Electrophysiology · 2026

DOI: 10.1111/jce.70214 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2026. Verfasst von Sandeep A Saha und 8 weiteren Autor:innen. Beteiligte Einrichtung: Oregon Heart Center, Salem, Oregon, USA. Hauptthemen laut MEDLINE: Arrhythmias, Cardiac, Electrocardiography, Ambulatory, Heart Rate. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medtronic..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Insertable cardiac monitors (ICMs) provide long‐term continuous monitoring for arrhythmia diagnosis and management for various clinical indications. However, little data exists on comprehensive real‐world arrhythmia diagnostic yield and therapy rates in patients indicated for ICMs with validated artificial intelligence (AI) algorithms enabling large‐scale, automated adjudication of ICM‐detected episodes. We report the largest real‐world analysis of arrhythmia detection as well as medical and procedural therapies in patients with ICMs implanted for guideline‐approved indications with long‐term monitoring.

Methods

Patients who received a Reveal LINQ ICM between October 1, 2016, and June 30, 2020, with ≥ 1 year of follow‐up were identified in two databases (Medtronic CareLink data warehouse, N = 12 020, and Optum Clinformatics Data Mart claims database, N = 17 037) to analyze arrhythmia detections and therapeutic interventions, respectively. Patients were categorized by clinical indication for ICM placement. All device‐detected ECGs were identified and processed through arrhythmia‐specific AI algorithms. Therapeutic interventions included procedural interventions (cardiovascular implantable electronic device implantation, cardioversions, and ablations) and medication initiation or titration (antiarrhythmics, rate‐control medications, and oral anticoagulants) after ICM implant.

Results

Mean (SD) follow‐up in the CareLink and Clinformatics claims databases was 24.6 (12.7) and 40.8 (15.6) months, respectively. Of the 12 020 patients in the arrhythmia detection analysis, 7284 (60.6%) had ≥ 1 arrhythmia detected (56.3% in the suspected AF population; 80.1% in the AF management population), and 376 (28.9%) had ≥ 2 arrhythmias detected during long‐term follow‐up. Among syncope patients with arrhythmia(s) detected, 71.2% had a finding other than pause/bradycardia; 50.4% of cryptogenic stroke patients and 62.6% of AF management patients with arrhythmias had ≥ 1 finding other than AF. Of the 17 037 patients in the therapeutic interventions analysis, 9820 (57.6%) had a therapeutic action post‐ICM insertion, with 25% of all patients receiving a procedural intervention, and > 50% undergoing a medication adjustment. Mean (SD) follow‐up to first arrhythmia detection was 7 (9) months. Mean (SD) duration from ICM insertion to therapeutic action was 13 (13) months for procedures and 7 (11) months for medication initiation.

Conclusions

Long‐term continuous monitoring with ICMs enables identification of multiple arrhythmias that may have otherwise remained undetected and rules out arrhythmias in ~40% regardless of indication. Medication adjustments and/or procedural interventions related to the management of arrhythmias were observed in over half of ICM recipients during long‐term follow‐up.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arrhythmias, CardiacElectrocardiography, AmbulatoryHeart RateHumansFemaleMaleTime FactorsMiddle AgedAgedPredictive Value of TestsDatabases, FactualAction PotentialsTreatment OutcomeArtificial IntelligenceRetrospective StudiesAlgorithmsSignal Processing, Computer-Assisted

Stichwörter der Autor:innen

arrhythmiasatrial fibrillationcardiac implantable electronic devicecryptogenic strokediagnostic yieldinsertable cardiac monitorsyncope

Autor:innen und Institutionen

  • Oregon Heart Center, Salem, Oregon, USA.
  • Medtronic Cardiac Diagnostics & Services, Mounds View, Minnesota, USA.
  • Bakken Research Center, Maastricht, the Netherlands.
  • Grifols Shared Services North America, Los Angeles, California, USA.

ORCID-Profile: Sandeep A Saha, Sarah Rosemas, Shantanu Sarkar, Mirko De Melis

Förderung

  • Medtronic.

Zitieren

APA

Saha, S. A., Rosemas, S., Sarkar, S., Ramos, V., Radtke, A. P., Majumder, S., De Melis, M., Zhou, J., & Jason Sims, J. (2026). A Large, Real‐World Cohort Analysis of Arrhythmia Detection and Therapeutic Interventions in Patients With Insertable Cardiac Monitors and Long‐Term Monitoring. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.70214

Vancouver

Saha SA, Rosemas S, Sarkar S, Ramos V, Radtke AP, Majumder S, et al. A Large, Real‐World Cohort Analysis of Arrhythmia Detection and Therapeutic Interventions in Patients With Insertable Cardiac Monitors and Long‐Term Monitoring. Journal of Cardiovascular Electrophysiology. 2026. doi:10.1111/jce.70214

BibTeX
@article{Saha2026,
  author = {Saha, Sandeep A and Rosemas, Sarah and Sarkar, Shantanu and Ramos, Veronica and Radtke, Andrew P and Majumder, Shubha and De Melis, Mirko and Zhou, Jiani and Jason Sims, J},
  title = {A Large, Real‐World Cohort Analysis of Arrhythmia Detection and Therapeutic Interventions in Patients With Insertable Cardiac Monitors and Long‐Term Monitoring},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2026},
  doi = {10.1111/jce.70214}
}
Kostenlos starten →